Fingerprint Dive into the research topics of 'Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer
PACIFIC Investigators
Research output: Contribution to journal › Article › peer-review
1479
Citations
(Scopus)